{"id":25221,"date":"2024-12-13T16:56:35","date_gmt":"2024-12-13T19:56:35","guid":{"rendered":"https:\/\/ocanal.com\/noticias\/corporativas\/o-faam-eurobat-2024-termina-com-avancos-inovadores-na-investigacao-de-alergias-alimentares-e-anafilaxia\/"},"modified":"2024-12-13T16:56:35","modified_gmt":"2024-12-13T19:56:35","slug":"o-faam-eurobat-2024-termina-com-avancos-inovadores-na-investigacao-de-alergias-alimentares-e-anafilaxia","status":"publish","type":"post","link":"https:\/\/ocanal.com\/noticias\/corporativas\/o-faam-eurobat-2024-termina-com-avancos-inovadores-na-investigacao-de-alergias-alimentares-e-anafilaxia\/","title":{"rendered":"O FAAM-EUROBAT 2024 termina com avan\u00e7os inovadores na investiga\u00e7\u00e3o de alergias alimentares e anafilaxia"},"content":{"rendered":"<link type=\"text\/css\" rel=\"stylesheet\" href=\"https:\/\/www.globenewswire.com\/styles\/gnw_nitf.css\">\n<p align=\"center\"><img loading=\"lazy\" decoding=\"async\" alt=\"FAMM-EUROBAT 2024\" height=\"102\" name=\"GNW_RichHtml_External_IMG\" src=\"https:\/\/ml-eu.globenewswire.com\/Resource\/Download\/d87bd288-3647-4ca4-a52b-b9137d448290\/image2.png\" width=\"600\"><\/p>\n<p>ATENAS, Gr\u00e9cia, Dec.  13, 2024  (GLOBE NEWSWIRE) &#8212; O <strong>FAAM-EUROBAT 2024<\/strong>, realizado de 21 a 23 de novembro na InterContinental Athenaeum Athens, reuniu mais de <strong>550 participantes<\/strong> de mais de 25 pa\u00edses para partilhar os mais recentes avan\u00e7os na <strong>investiga\u00e7\u00e3o sobre alergias alimentares e anafilaxia<\/strong>.<\/p>\n<p>O evento contou com sess\u00f5es, debates, workshops e discuss\u00f5es plen\u00e1rias impactantes, real\u00e7ando as novas evid\u00eancias e a import\u00e2ncia da colabora\u00e7\u00e3o ao enfrentar os desafios de sa\u00fade nas alergias alimentares e na anafilaxia.<\/p>\n<p>Um momento de destaque foi o primeiro <strong>Dia Mundial da Sensibiliza\u00e7\u00e3o para a Anafilaxia<\/strong>, a <strong>21 de novembro<\/strong>, criado pela <strong>EAACI<\/strong> para promover a sensibiliza\u00e7\u00e3o global sobre esta condi\u00e7\u00e3o potencialmente fatal. Apresentada durante a <strong>Cerim\u00f3nia de Abertura<\/strong>, esta iniciativa deu o mote para um encontro inspirador.<\/p>\n<p>Um ponto de destaque foi a sess\u00e3o plen\u00e1ria onde foram apresentadas as novas orienta\u00e7\u00f5es sobre alergias alimentares.\u00a0<strong>Tanya e Nadim Ednan-Laperouse<\/strong>, fundadores da <strong>The Natasha Allergy Research Foundation, <\/strong>forneceram um testemunho comovente de partilha das suas hist\u00f3rias pessoais e esfor\u00e7os de defesa, incluindo a <strong>Natasha\u2019s Law<\/strong> (Lei de Natasha), que exige uma rotulagem mais clara dos alerg\u00e9nios para proteger quem sofre de alergias alimentares.<\/p>\n<p>O <strong>lan\u00e7amento das Orienta\u00e7\u00f5es sobre Alergias Alimentares da EAACI<\/strong> assinalou um marco cl\u00ednico, oferecendo recomenda\u00e7\u00f5es abrangentes para melhorar os resultados dos pacientes. Os workshops forneceram <strong>informa\u00e7\u00f5es mais profundas sobre a imunoterapia com alerg\u00e9nios<\/strong> e novos mecanismos imunit\u00e1rios para aumentar a efic\u00e1cia do tratamento.<\/p>\n<p><strong>As Sess\u00f5es de Cartazes<\/strong> apresentaram investiga\u00e7\u00e3o de ponta, real\u00e7ando abordagens inovadoras e solu\u00e7\u00f5es pr\u00e1ticas para avan\u00e7ar no tratamento de alergias e imunologia.<\/p>\n<p>O FAAM-EUROBAT 2024 proporcionou uma plataforma excecional para a troca de conhecimentos e networking, promovendo colabora\u00e7\u00f5es entre m\u00e9dicos, investigadores e representantes dos pacientes.<\/p>\n<p>A Professora Alexandra Santos, Copresidente da FAAM-EUROBAT 2024, afirmou:<br \/><em>&#8220;A confer\u00eancia EAACI FAAM-EUROBAT deste ano foi uma prova do poder da ci\u00eancia e da colabora\u00e7\u00e3o entre m\u00e9dicos, cientistas e pacientes com experi\u00eancia de vida. Desde o lan\u00e7amento do Dia Mundial da Sensibiliza\u00e7\u00e3o para a Anafilaxia at\u00e9&agrave;revela\u00e7\u00e3o de evid\u00eancias cient\u00edficas in\u00e9ditas e ao lan\u00e7amento das novas orienta\u00e7\u00f5es cl\u00ednicas para a gest\u00e3o de alergias alimentares mediada por IgE, o FAAM-EUROBAT 2024 estabeleceu uma refer\u00eancia na luta contra as alergias alimentares e a anafilaxia.&#8221;<\/em><\/p>\n<p>No final da reuni\u00e3o, os participantes sa\u00edram inspirados e equipados com novos conhecimentos para melhorar os cuidados prestados aos pacientes. O FAAM-EUROBAT 2024 celebrou o progresso cient\u00edfico e refor\u00e7ou a import\u00e2ncia da coopera\u00e7\u00e3o global na abordagem aos desafios de sa\u00fade prementes nas alergias alimentares e na anafilaxia.<\/p>\n<p><strong>Sobre a EAACI<\/strong>\u00a0<\/p>\n<p>A European Academy of Allergy and Clinical Immunology \u00e9 a principal organiza\u00e7\u00e3o para os profissionais de alergia e imunologia cl\u00ednicas. A EAACI promove a excel\u00eancia no tratamento cl\u00ednico, investiga\u00e7\u00e3o, educa\u00e7\u00e3o e forma\u00e7\u00e3o em alergia e imunologia cl\u00ednicas.\u00a0<br \/>&#8211; https:\/\/eaaci.org<\/p>\n<p>Comit\u00e9 organizador:<br \/>Isabel Skypala, Alberto \u00c1lvarez-Perea, Alexandra F. Santos, Nikos Papadoupoulos, Sophia Tsabouri, Liam O\u2019Mahony, Bernadette Eberlein, Andr\u00e9 Moreira<\/p>\n<p><strong>Contacto:<\/strong><br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=QA--8pFU-lUK9bB5N2kjuO7tCFMpQ3ohVPolBIdaJuU28FhGyv1u-WTjVZcfIFtCrx5cy6OV9C1cygTrO9z3jhP9mimACvvB2oQ_6IoXvVZ3MfpzhfOBb34_2NRTp8QH\" rel=\"follow\" target=\"_blank\">communications@eaaci.org<\/a><br \/>+41 44 205 55 33\u00a0<\/p>\n<p align=\"center\"><img loading=\"lazy\" decoding=\"async\" alt=\"World Anaphylaxis Awareness Day\" data-mce-selected=\"1\" height=\"83\" name=\"GNW_RichHtml_External_IMG\" src=\"https:\/\/ml-eu.globenewswire.com\/Resource\/Download\/ed1995c4-7c7c-48cb-9d93-ee0f8159da77\/image1.png\" width=\"600\"><\/p>\n<p>As fotos que acompanham este an\u00fancio est\u00e3o dispon\u00edveis em:<\/p>\n<p><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-JASM1Tje7eMSJDQ-rNTHIazb9e-STNsoL-ctE0F-q_YsnJIWo7rlxzCrBlgSLbp5qgZS-W41lP4wC3TcLwrdD9cDSDsBqHJClD2O2woXnTTqvcigAxuC7cuZPdj77I1AN1n0E7DAYx7wobbaINhjXXuJ9-3QTT5vT0iKrkHqP5kMRUSSj6goPjBkTI_hAWJvURFf_dpR9Bw4Q67shtS-cVcHEe8MNbju71-B-JJ-7qzp4onvC2FGPWOgKPFFnoFfFDo_JSQYrS5_BxeDJUlwg==\" rel=\"follow\" target=\"_blank\">https:\/\/www.globenewswire.com\/NewsRoom\/AttachmentNg\/d87bd288-3647-4ca4-a52b-b9137d448290<\/a><\/p>\n<p><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-JASM1Tje7eMSJDQ-rNTHIazb9e-STNsoL-ctE0F-q_YsnJIWo7rlxzCrBlgSLbp5qgZS-W41lP4wC3TcLwrdLpu9sfW6tMgUb7qm_xxx4YxcWL9m5mZBxYIRFN2f3erIDHpD7AxQIM9wln5wIJlx_g8TlwXmdIkOV5v-CbTKBmGgx0q8wfiB19MRYxcQKiWNLo64qY0Y_i1EDILFRT8yMh80JhJ-KJBZHzoJN8pAijb40igzfQL5pMMnA6ZIUsWAlOWsTBQ6RL-iIFtYaWGAA==\" rel=\"follow\" target=\"_blank\">https:\/\/www.globenewswire.com\/NewsRoom\/AttachmentNg\/ed1995c4-7c7c-48cb-9d93-ee0f8159da77<\/a><\/p>\n<p><img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTAyODY4NSM0MDIwMjE2MDgjMjI2MTMzNw==\"><br \/><img decoding=\"async\" alt=\"\" src=\"https:\/\/ml-eu.globenewswire.com\/media\/MWIzN2FhNDMtNDNmNC00ZGRjLThmMDEtOTgzZTY5ZDM4M2NhLTEyNzI4ODc=\/tiny\/European-Academy-of-Allergy-an.png\" referrerpolicy=\"no-referrer-when-downgrade\"><\/p>\n<p><a href=\"https:\/\/www.globenewswire.com\/NewsRoom\/AttachmentNg\/f4b92ae8-0022-43fa-b8a3-bbe4246a45cd\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/ml-eu.globenewswire.com\/media\/f4b92ae8-0022-43fa-b8a3-bbe4246a45cd\/small\/eaaci-logo-png.png\" border=\"0\" width=\"150\" height=\"34\" alt=\"Primary Logo\"><\/a><\/p>\n<p> GLOBENEWSWIRE (Distribution ID 1001028685)<img src='https:\/\/api.dino.com.br\/v2\/news\/tr\/311391?partnerId=3197' alt=\"\" style=\"border:0px;width:1px;height:1px;\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>ATENAS, Gr\u00e9cia, Dec. 13, 2024 (GLOBE NEWSWIRE) &#8212; O FAAM-EUROBAT 2024, realizado de 21 a 23 de novembro na InterContinental Athenaeum Athens, reuniu mais de 550 participantes de mais de 25 pa\u00edses para partilhar os mais recentes avan\u00e7os na investiga\u00e7\u00e3o sobre alergias alimentares e anafilaxia. O evento contou com sess\u00f5es, debates, workshops e discuss\u00f5es plen\u00e1rias [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[],"class_list":["post-25221","post","type-post","status-publish","format-standard","hentry","category-noticias"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>O FAAM-EUROBAT 2024 termina com avan\u00e7os inovadores na investiga\u00e7\u00e3o de alergias alimentares e anafilaxia - Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ocanal.com\/noticias\/corporativas\/o-faam-eurobat-2024-termina-com-avancos-inovadores-na-investigacao-de-alergias-alimentares-e-anafilaxia\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"O FAAM-EUROBAT 2024 termina com avan\u00e7os inovadores na investiga\u00e7\u00e3o de alergias alimentares e anafilaxia - Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios\" \/>\n<meta property=\"og:description\" content=\"ATENAS, Gr\u00e9cia, Dec. 13, 2024 (GLOBE NEWSWIRE) &#8212; O FAAM-EUROBAT 2024, realizado de 21 a 23 de novembro na InterContinental Athenaeum Athens, reuniu mais de 550 participantes de mais de 25 pa\u00edses para partilhar os mais recentes avan\u00e7os na investiga\u00e7\u00e3o sobre alergias alimentares e anafilaxia. O evento contou com sess\u00f5es, debates, workshops e discuss\u00f5es plen\u00e1rias [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ocanal.com\/noticias\/corporativas\/o-faam-eurobat-2024-termina-com-avancos-inovadores-na-investigacao-de-alergias-alimentares-e-anafilaxia\/\" \/>\n<meta property=\"og:site_name\" content=\"Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios\" \/>\n<meta property=\"article:published_time\" content=\"2024-12-13T19:56:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ml-eu.globenewswire.com\/Resource\/Download\/d87bd288-3647-4ca4-a52b-b9137d448290\/image2.png\" \/>\n<meta name=\"author\" content=\"DINO\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"DINO\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/o-faam-eurobat-2024-termina-com-avancos-inovadores-na-investigacao-de-alergias-alimentares-e-anafilaxia\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/o-faam-eurobat-2024-termina-com-avancos-inovadores-na-investigacao-de-alergias-alimentares-e-anafilaxia\\\/\"},\"author\":{\"name\":\"DINO\",\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/#\\\/schema\\\/person\\\/24f7b50e924d81f1023b69582993c0ff\"},\"headline\":\"O FAAM-EUROBAT 2024 termina com avan\u00e7os inovadores na investiga\u00e7\u00e3o de alergias alimentares e anafilaxia\",\"datePublished\":\"2024-12-13T19:56:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/o-faam-eurobat-2024-termina-com-avancos-inovadores-na-investigacao-de-alergias-alimentares-e-anafilaxia\\\/\"},\"wordCount\":590,\"image\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/o-faam-eurobat-2024-termina-com-avancos-inovadores-na-investigacao-de-alergias-alimentares-e-anafilaxia\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ml-eu.globenewswire.com\\\/Resource\\\/Download\\\/d87bd288-3647-4ca4-a52b-b9137d448290\\\/image2.png\",\"articleSection\":[\"Not\u00edcias Corporativas\"],\"inLanguage\":\"pt-BR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/o-faam-eurobat-2024-termina-com-avancos-inovadores-na-investigacao-de-alergias-alimentares-e-anafilaxia\\\/\",\"url\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/o-faam-eurobat-2024-termina-com-avancos-inovadores-na-investigacao-de-alergias-alimentares-e-anafilaxia\\\/\",\"name\":\"O FAAM-EUROBAT 2024 termina com avan\u00e7os inovadores na investiga\u00e7\u00e3o de alergias alimentares e anafilaxia - Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/o-faam-eurobat-2024-termina-com-avancos-inovadores-na-investigacao-de-alergias-alimentares-e-anafilaxia\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/o-faam-eurobat-2024-termina-com-avancos-inovadores-na-investigacao-de-alergias-alimentares-e-anafilaxia\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ml-eu.globenewswire.com\\\/Resource\\\/Download\\\/d87bd288-3647-4ca4-a52b-b9137d448290\\\/image2.png\",\"datePublished\":\"2024-12-13T19:56:35+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/#\\\/schema\\\/person\\\/24f7b50e924d81f1023b69582993c0ff\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/o-faam-eurobat-2024-termina-com-avancos-inovadores-na-investigacao-de-alergias-alimentares-e-anafilaxia\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/o-faam-eurobat-2024-termina-com-avancos-inovadores-na-investigacao-de-alergias-alimentares-e-anafilaxia\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/o-faam-eurobat-2024-termina-com-avancos-inovadores-na-investigacao-de-alergias-alimentares-e-anafilaxia\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ml-eu.globenewswire.com\\\/Resource\\\/Download\\\/d87bd288-3647-4ca4-a52b-b9137d448290\\\/image2.png\",\"contentUrl\":\"https:\\\/\\\/ml-eu.globenewswire.com\\\/Resource\\\/Download\\\/d87bd288-3647-4ca4-a52b-b9137d448290\\\/image2.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/o-faam-eurobat-2024-termina-com-avancos-inovadores-na-investigacao-de-alergias-alimentares-e-anafilaxia\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"O FAAM-EUROBAT 2024 termina com avan\u00e7os inovadores na investiga\u00e7\u00e3o de alergias alimentares e anafilaxia\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/#website\",\"url\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/\",\"name\":\"Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios\",\"description\":\"Tudo sobre o mercado empresarial, comunicados e neg\u00f3cios\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/#\\\/schema\\\/person\\\/24f7b50e924d81f1023b69582993c0ff\",\"name\":\"DINO\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ca8348556b3dfd41c825da9ac5643583f369a1092022fb6057420d716f02be0c?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ca8348556b3dfd41c825da9ac5643583f369a1092022fb6057420d716f02be0c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ca8348556b3dfd41c825da9ac5643583f369a1092022fb6057420d716f02be0c?s=96&d=mm&r=g\",\"caption\":\"DINO\"},\"url\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/author\\\/dino\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"O FAAM-EUROBAT 2024 termina com avan\u00e7os inovadores na investiga\u00e7\u00e3o de alergias alimentares e anafilaxia - Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ocanal.com\/noticias\/corporativas\/o-faam-eurobat-2024-termina-com-avancos-inovadores-na-investigacao-de-alergias-alimentares-e-anafilaxia\/","og_locale":"pt_BR","og_type":"article","og_title":"O FAAM-EUROBAT 2024 termina com avan\u00e7os inovadores na investiga\u00e7\u00e3o de alergias alimentares e anafilaxia - Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios","og_description":"ATENAS, Gr\u00e9cia, Dec. 13, 2024 (GLOBE NEWSWIRE) &#8212; O FAAM-EUROBAT 2024, realizado de 21 a 23 de novembro na InterContinental Athenaeum Athens, reuniu mais de 550 participantes de mais de 25 pa\u00edses para partilhar os mais recentes avan\u00e7os na investiga\u00e7\u00e3o sobre alergias alimentares e anafilaxia. O evento contou com sess\u00f5es, debates, workshops e discuss\u00f5es plen\u00e1rias [&hellip;]","og_url":"https:\/\/ocanal.com\/noticias\/corporativas\/o-faam-eurobat-2024-termina-com-avancos-inovadores-na-investigacao-de-alergias-alimentares-e-anafilaxia\/","og_site_name":"Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios","article_published_time":"2024-12-13T19:56:35+00:00","og_image":[{"url":"https:\/\/ml-eu.globenewswire.com\/Resource\/Download\/d87bd288-3647-4ca4-a52b-b9137d448290\/image2.png","type":"","width":"","height":""}],"author":"DINO","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"DINO","Est. tempo de leitura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ocanal.com\/noticias\/corporativas\/o-faam-eurobat-2024-termina-com-avancos-inovadores-na-investigacao-de-alergias-alimentares-e-anafilaxia\/#article","isPartOf":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/o-faam-eurobat-2024-termina-com-avancos-inovadores-na-investigacao-de-alergias-alimentares-e-anafilaxia\/"},"author":{"name":"DINO","@id":"https:\/\/ocanal.com\/noticias\/corporativas\/#\/schema\/person\/24f7b50e924d81f1023b69582993c0ff"},"headline":"O FAAM-EUROBAT 2024 termina com avan\u00e7os inovadores na investiga\u00e7\u00e3o de alergias alimentares e anafilaxia","datePublished":"2024-12-13T19:56:35+00:00","mainEntityOfPage":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/o-faam-eurobat-2024-termina-com-avancos-inovadores-na-investigacao-de-alergias-alimentares-e-anafilaxia\/"},"wordCount":590,"image":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/o-faam-eurobat-2024-termina-com-avancos-inovadores-na-investigacao-de-alergias-alimentares-e-anafilaxia\/#primaryimage"},"thumbnailUrl":"https:\/\/ml-eu.globenewswire.com\/Resource\/Download\/d87bd288-3647-4ca4-a52b-b9137d448290\/image2.png","articleSection":["Not\u00edcias Corporativas"],"inLanguage":"pt-BR"},{"@type":"WebPage","@id":"https:\/\/ocanal.com\/noticias\/corporativas\/o-faam-eurobat-2024-termina-com-avancos-inovadores-na-investigacao-de-alergias-alimentares-e-anafilaxia\/","url":"https:\/\/ocanal.com\/noticias\/corporativas\/o-faam-eurobat-2024-termina-com-avancos-inovadores-na-investigacao-de-alergias-alimentares-e-anafilaxia\/","name":"O FAAM-EUROBAT 2024 termina com avan\u00e7os inovadores na investiga\u00e7\u00e3o de alergias alimentares e anafilaxia - Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios","isPartOf":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/o-faam-eurobat-2024-termina-com-avancos-inovadores-na-investigacao-de-alergias-alimentares-e-anafilaxia\/#primaryimage"},"image":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/o-faam-eurobat-2024-termina-com-avancos-inovadores-na-investigacao-de-alergias-alimentares-e-anafilaxia\/#primaryimage"},"thumbnailUrl":"https:\/\/ml-eu.globenewswire.com\/Resource\/Download\/d87bd288-3647-4ca4-a52b-b9137d448290\/image2.png","datePublished":"2024-12-13T19:56:35+00:00","author":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/#\/schema\/person\/24f7b50e924d81f1023b69582993c0ff"},"breadcrumb":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/o-faam-eurobat-2024-termina-com-avancos-inovadores-na-investigacao-de-alergias-alimentares-e-anafilaxia\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ocanal.com\/noticias\/corporativas\/o-faam-eurobat-2024-termina-com-avancos-inovadores-na-investigacao-de-alergias-alimentares-e-anafilaxia\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/ocanal.com\/noticias\/corporativas\/o-faam-eurobat-2024-termina-com-avancos-inovadores-na-investigacao-de-alergias-alimentares-e-anafilaxia\/#primaryimage","url":"https:\/\/ml-eu.globenewswire.com\/Resource\/Download\/d87bd288-3647-4ca4-a52b-b9137d448290\/image2.png","contentUrl":"https:\/\/ml-eu.globenewswire.com\/Resource\/Download\/d87bd288-3647-4ca4-a52b-b9137d448290\/image2.png"},{"@type":"BreadcrumbList","@id":"https:\/\/ocanal.com\/noticias\/corporativas\/o-faam-eurobat-2024-termina-com-avancos-inovadores-na-investigacao-de-alergias-alimentares-e-anafilaxia\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/ocanal.com\/noticias\/corporativas\/"},{"@type":"ListItem","position":2,"name":"O FAAM-EUROBAT 2024 termina com avan\u00e7os inovadores na investiga\u00e7\u00e3o de alergias alimentares e anafilaxia"}]},{"@type":"WebSite","@id":"https:\/\/ocanal.com\/noticias\/corporativas\/#website","url":"https:\/\/ocanal.com\/noticias\/corporativas\/","name":"Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios","description":"Tudo sobre o mercado empresarial, comunicados e neg\u00f3cios","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ocanal.com\/noticias\/corporativas\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Person","@id":"https:\/\/ocanal.com\/noticias\/corporativas\/#\/schema\/person\/24f7b50e924d81f1023b69582993c0ff","name":"DINO","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/secure.gravatar.com\/avatar\/ca8348556b3dfd41c825da9ac5643583f369a1092022fb6057420d716f02be0c?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/ca8348556b3dfd41c825da9ac5643583f369a1092022fb6057420d716f02be0c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ca8348556b3dfd41c825da9ac5643583f369a1092022fb6057420d716f02be0c?s=96&d=mm&r=g","caption":"DINO"},"url":"https:\/\/ocanal.com\/noticias\/corporativas\/author\/dino\/"}]}},"_links":{"self":[{"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/posts\/25221","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/comments?post=25221"}],"version-history":[{"count":0,"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/posts\/25221\/revisions"}],"wp:attachment":[{"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/media?parent=25221"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/categories?post=25221"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/tags?post=25221"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}